Your browser doesn't support javascript.
loading
Anti-CD20 antibody promotes cancer escape via enrichment of tumor-evoked regulatory B cells expressing low levels of CD20 and CD137L.
Bodogai, Monica; Lee Chang, Catalina; Wejksza, Katarzyna; Lai, Jinping; Merino, Maria; Wersto, Robert P; Gress, Ronald E; Chan, Andrew C; Hesdorffer, Charles; Biragyn, Arya.
Affiliation
  • Bodogai M; Immunotherapeutic Section, National Institute on Aging, Baltimore, MD 21224, USA.
Cancer Res ; 73(7): 2127-38, 2013 Apr 01.
Article in En | MEDLINE | ID: mdl-23365136
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Melanoma, Experimental / Breast Neoplasms / Leukemia, Lymphocytic, Chronic, B-Cell / Antigens, CD20 / 4-1BB Ligand / B-Lymphocytes, Regulatory / Lung Neoplasms / Antibodies, Monoclonal Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Cancer Res Year: 2013 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Melanoma, Experimental / Breast Neoplasms / Leukemia, Lymphocytic, Chronic, B-Cell / Antigens, CD20 / 4-1BB Ligand / B-Lymphocytes, Regulatory / Lung Neoplasms / Antibodies, Monoclonal Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Cancer Res Year: 2013 Document type: Article Affiliation country: United States Country of publication: United States